Carfilzomib (PR-171)
Inquiry
| Post Date: | Apr 03,2015 |
| Expiry Date: | Apr 02,2016 |
| Detailed Description: |
Cas No. :868540-17-4
Quantity: 50g Specs:98% purity Payment Method: T/T, Western Union Carfilzomib (PR-171) is a proteasome inhibitor with IC50 less than 5 nM. Carfilzomib (CFZ, marketed under the tradename Kyprolis) is a tetrapeptide epoxyketone and a selective proteasome inhibitor. It is an analog of epoxomicin. The US FDA approved it for relapsed and refractory multiple myeloma on 20 July 2012. |
| CAS Registry Number: | 868540-17-4 |
| Synonyms: | ;Carfilzomib(PR-171);PX-171-007;N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide;(S)-2-((S)-2-(2-(2H-1,4-oxazin-4(3H)-yl) acetamido)-4-phenylbutanamide)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)pentanamide; |
| Molecular Formula: | C40H57N5O7 |
| Molecular Weight: | 719.9099 |
| Molecular Structure: | 
|
| Company: | Shanghai Sun-shineChemical Technology Co.,Ltd. [ China ] |
| Contact: | Rosie |
| Tel: | +86-027-59253327 |
| Fax: | 0086-27-5925 3326 |
| Email: | sales02@sun-shinechem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
